I

Iterum Therapeutics plc

D
ITRM
USD
0.055
(4.4534%)
Market Closed
14,499.00
Volume
-1.03
EPS
-
Div Yield
-0.686775
P/E
29,290,732.26
Market Cap
Today
4.4534%
1 Week
1.176%
1 Month
34.375%
6 Months
-7.026%
12 Months
93.288%
Year To Date
-27.278%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
G
GNPX
0.1
(6.3492%)
USD
M
MVIS
-0.045
(-4.186%)
USD
S
SNDL
0.005
(0.2427%)
USD
M
MARK
(%)
USD
Z
ZOM
0.003
(2.4834%)
USD
PLTR
PLTR
0.36
(0.6485%)
USD
B
BNGO
-0.0061
(-2.0327%)
USD
S
SOS
-0.01
(-1.3699%)
USD
T
TTOO
0.029
(4.1968%)
USD

Title:
Iterum Therapeutics plc

Sector:
Healthcare
Industry:
Biotechnology
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
Do you need help or have a question?
Contact Us